Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Hiv Dtg'

Hiv Dtg published presentations and documents on DocSlides.

DTG + 3TC versus DTG + TDF-FTC as Initial ART

DTG + 3TC versus DTG + TDF-FTC as Initial ART

  • della
  • 17 Slides

GEMINI 1 and GEMINI 2: Week 48 Data. DTG + 3TC . v...

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

DTG + TAF/FTC vs DTG + TDF/FTC vs EFV/TDF/FTC

  • iris
  • 11 Slides

ADVANCE. . Design. Primary endpoint. Proportion ...

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV: ADVANCE and NAMSAL trials

  • luanne-stotts
  • 31 Slides

Progressive rises in weight and clinical obesity ...

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

Progressive rises in weight and clinical obesity for TAF/FTC+DTG and TDF/FTC+DTG versus TDF/FTC/EFV

  • kylo
  • 31 Slides

Andrew Hill, Francois Venter, Eric . Delaporte. , ...

DTG/3TC 1st line (GEMINI)

DTG/3TC 1st line (GEMINI)

  • oryan
  • 37 Slides

ARV . strategies. DOR > DRV/r 1st line. (DRIVE-...

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

DURABLE EFFICACY OF DOLUTEGRAVIR (DTG) PLUS LAMIVUDINE (3TC) IN ANTIRETROVIRAL TREATMENT

  • jasmine
  • 15 Slides

–. NAIVE ADULTS WITH HIV-1 INFECTION: 96-WEEK RE...

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

SWITCHING TO DTG/3TC FIXED-DOSE COMBINATION (FDC) IS NON-INFERIOR TO CONTINUING A TAF-BASED REGIMEN

  • jacey
  • 17 Slides

1. ViiV Healthcare, Brentford, UK; . 2. Centre Hos...

10 th International Pediatric HIV Workshop

10 th International Pediatric HIV Workshop

  • luanne-stotts
  • 0 Slides

and 22. nd. International AIDS Conference . Sele...

Potential safety issue affecting women living with HIV using

Potential safety issue affecting women living with HIV using

  • luanne-stotts
  • 0 Slides

dolutegravir. at the time of conception. Meg Doh...

10 th International Pediatric HIV Workshop

10 th International Pediatric HIV Workshop

  • faustina-dinatale
  • 0 Slides

and 22. nd. International AIDS Conference . Sele...

Heather Watts MD Director of HIV Prevention, Program Quality Team

Heather Watts MD Director of HIV Prevention, Program Quality Team

  • alida-meadow
  • 22 Slides

Heather Watts MD Director of HIV Prevention, Pro...

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

CROI 2019: ARV for Prevention and Treatment, HIV Pathogenesis, and Cure

  • brown
  • 34 Slides

Joseph J. Eron, Jr, MD. Professor of Medicine. Uni...

Basic HIV Course for Health Professionals

Basic HIV Course for Health Professionals

  • megan
  • 13 Slides

Session 12: Contraceptives and HIV. Learning Objec...

Updates on Individual and Universal HIV Treatment Strategies

Updates on Individual and Universal HIV Treatment Strategies

  • norah
  • 33 Slides

EECA INTERACT, November 19, 2019. Stefan Baral, MD...

DTG-Based Regimens Are Active in INI-Naive Patients With a

DTG-Based Regimens Are Active in INI-Naive Patients With a

  • trish-goza
  • 14 Slides

Jim Demarest. ,. 1. Mark Underwood,. 2. Marty S...

Switch to DTG/ABC/3TC

Switch to DTG/ABC/3TC

  • karlyn-bohler
  • 10 Slides

STRIIVING . Study. Design. Endpoints. Primary: pr...

Superior Efficacy of Dolutegravir (DTG) Plus

Superior Efficacy of Dolutegravir (DTG) Plus

  • celsa-spraggs
  • 0 Slides

2 Nucleoside Reverse Transcriptase Inhibitors (NR...

Switch to DTG/3TC TANGO Design

Switch to DTG/3TC TANGO Design

  • lam
  • 10 Slides

Endpoints. Primary: proportion of patients with HI...

DTG vs LPV/r (DAWNING): Efficacy

DTG vs LPV/r (DAWNING): Efficacy

  • winnie
  • 12 Slides

by Baseline NRTI Resistance . and Second-Line NRTI...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 17 Slides

FLAMINGO. GS-236-0103. ACTG . A5257. WAVES. . De...

Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications

Session - Safety of DTG in Pregnancy: Late Breaking Findings, Interpretations, Implications

  • liane-varnes
  • 0 Slides

July 24 2018 . Overview on Safety of HIV Treatmen...

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

Opportunities for the use of new ARVs for infants, children and adolescents and updated guidance on

  • myesha-ticknor
  • 0 Slides

Martina Penazzato MD, PhD. Paediatric lead, HIV D...

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. Myer, J. Kaboggoza, B. Simmons, L. Else, C. Heiberg, C. Waitt, S.

  • liane-varnes
  • 12 Slides

C. Orrell , K. Kintu, J.A. Coombs, A. Amara, L. ...

The SA National PMTCT Guidelines (2019)

The SA National PMTCT Guidelines (2019)

  • cleminal
  • 49 Slides

Outline. The ideal PMTCT pathway . Detail of new i...

HIV History successes and lessons learned

HIV History successes and lessons learned

  • linda
  • 13 Slides

PADO-Dr Martina Penazzato MD MSc PhDPaediatricHIV ...

What’s new in the 2019 WHO Guidelines:

What’s new in the 2019 WHO Guidelines:

  • elina
  • 32 Slides

Dolutegravir based regimens in first- ad second-li...

Challenging Cases in Antiretroviral Therapy and Panel Discussion

Challenging Cases in Antiretroviral Therapy and Panel Discussion

  • gagnon
  • 73 Slides

Paul E. Sax, MD. Professor of Medicine. Harvard Me...

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

Thinking of Now and Tomorrow: Emerging Treatment Paradigms

  • deena
  • 32 Slides

Pedro Cahn. Disclosures. Advisory. . boards. : Me...

Optimization of Antiretroviral Therapy

Optimization of Antiretroviral Therapy

  • belinda
  • 26 Slides

With Emergence of Comorbidities. Roger J. . Bedimo...

Antiretrovirals for prevention in women of childbearing age:

Antiretrovirals for prevention in women of childbearing age:

  • tremblay
  • 30 Slides

issues to consider. Landon Myer. We all have “is...

HIV/AIDS HIV There are two types of HIV virus HIV 1 and HIV 2 ,most cases are caused by type 1 ,t

HIV/AIDS HIV There are two types of HIV virus HIV 1 and HIV 2 ,most cases are caused by type 1 ,t

  • phoebe
  • 12 Slides

HIV1 and slower to progress to AIDS.. Most cases a...

Comparison of INSTI vs PI

Comparison of INSTI vs PI

  • conchita-marotz
  • 6 Slides

FLAMINGO. GS-236-0103. ACTG A5257. WAVES. ARIA . ...

Projecting the Impact of

Projecting the Impact of

  • marina-yarberry
  • 0 Slides

Generic. HIV . Drugs. on 90-90-90. Esteban Burr...

1 Fundación Huésped, Buenos Aires, Argentina;

1 Fundación Huésped, Buenos Aires, Argentina;

  • aaron
  • 0 Slides

2. Instituto Nacional de Ciencias Médicas y Nutr...

Dolutegravir monotherapy

Dolutegravir monotherapy

  • alexa-scheidler
  • 15 Slides

Dolutegravir monotherapy vs. dolutegravir/ abac...

1 Queen Mary University, London, United Kingdom;

1 Queen Mary University, London, United Kingdom;

  • trish-goza
  • 15 Slides

1 Queen Mary University, London, United Kingdom; ...

What’s New in WHO Treatment Guidelines

What’s New in WHO Treatment Guidelines

  • aaron
  • 28 Slides

July 23 2018 . What We Know About Safety Signals ...

Comparison of INSTI vs EFV

Comparison of INSTI vs EFV

  • mediumgeneral
  • 12 Slides

STARTMRK. GS-US-236-0102 . SINGLE. Walmsley. S. N...

Comparison of INSTI vs INSTI

Comparison of INSTI vs INSTI

  • mediumgeneral
  • 10 Slides

QDMRK. SPRING-2. ONCEMRK. GS-US-380-1489. GS-US-38...

Meg Doherty MD MPH PhD 23 July 2018

Meg Doherty MD MPH PhD 23 July 2018

  • jordyn
  • 41 Slides

WHO HQ. The role of DTG based regimens in first- a...

Copyright © 2024 DocSlides. All Rights Reserved